Rogawski’s research encompasses cellular neurophysiological studies of ion channels (with a focus on the mechanisms of action of antiseizure medications); animal models of epilepsy, migraine, and nerve agent intoxication; and clinical studies on new treatments for seizures, epilepsy, migraine, traumatic brain injury, and neurodevelopmental disorders.
UC Davis Bioanalysis and Pharmacokinetics
-
Principal InvestigatorMichael Rogawski, M.D., Ph.D.
-
Our Research Goals
This laboratory studies on AMPA receptors and neurosteroids have led to new treatment approaches for seizures and epilepsy, and the marketed treatment for postpartum depression brexanolone (Zulresso™).
-
Our Team
- Dorota Zolkowska, M.D., Ph.D.
- Chun-Yi "Jimmy" Wu, Ph.D.
Clinical Trials
Learn about the different clinical trials we offer.
Giving
Join us to advance neurological health for all.
Fellowship Programs and Training Opportunities
Learn, grow and collaborate with our renowned researchers.